+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

China Sexually Transmitted Diseases (STD) Diagnostics Market 2019-2025

  • ID: 5116806
  • Report
  • February 2020
  • Region: China
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Danaher Corp.
  • Eli Lilly and Co.
China Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Human Immunodeficiency Virus (HIV), and Others), by Product (Laboratory Testing Devices, and Point-of-Care (POC) Testing Devices) by End-user (Hospitals and Clinics, Diagnostic Centers, and Homecare) Forecast Period 2019-2025.

China STD diagnostics market is growing at a CAGR of around 9.5% during the forecast period. China, which is one of the largest developing countries across the globe, has been suffering from the wide-spread of STDs for a long time. Among all of the STDs in China, three are listed as the notifiable infectious diseases, i.e., Gonorrhoea, Syphilis, and HIV/AIDS, which demand more attention, which is influencing the growth of the China STD diagnostics market. Overall, the Yangtze River Delta region, the southwestern border area, and some other border regions are the places demanding more attention.

The rate of STD in China has recently increased drastically over the years. In China, the high-risk community consists of migrants, workers, prostitutes and their clients, drug users, and homosexuals. Most of the STDs can be treated if it the disease is quickly diagnosed. In China, there are local specialized STD hospitals, including the Shanghai Skin Disease and other large and local hospitals such as Huashan hospital. These hospitals provide STD diagnosis tests across the region. Further, in 2016, the Chinese Centre for Disease Control and Prevention (CCDC) reported 96,000 new HIV cases in the first nine months. China has increased HIV testing efforts and changed its approach depending on the type of group or population being targeted.

In addition, Abbott Laboratories, Inc., AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd. among others are the key manufactures that encourages the China STD market growth. These market players are considerably contributing to the China STD diagnostic market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the China STD diagnostics market.

Research Methodology:

The market study of the China STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. China STD Diagnostics Market Research and Analysis by Disease Type
2. China STD Diagnostics Market Research and Analysis by Product
3. China STD Diagnostics Market Research and Analysis by End-user

The Report Covers:
  • Comprehensive Research Methodology of the China STD Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China STD Diagnostics market.
  • Insights about market determinants which are stimulating the China STD Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown